Executive Compensation and Employee Benefits Attorney Maureen O’Brien Moves to Holland & Knight | News

CHICAGO (October 15, 2020) – Executive Compensation and Employee Benefits Attorney Maureen O’ Brien has joined Holland & Knight in Chicago as a partner in the firm’s Corporate, M&A and Securities Practice Group. Most recently, she was a partner in the Employee Benefits and Executive Compensation Group at McDermott Will & Emery.

Ms. O’Brien focuses her practice on issues affecting executive compensation and employee benefit plans in sales, acquisitions, spin-offs, bankruptcy and restructuring, and other corporate transactions, as well as with benefit plan structuring and integration stemming from such transactions. Her clients include both public and privately held companies, as well as private equity and venture capital funds.

In addition to Ms. O’Brien’s transactional focus, she advises clients on complex retirement and multiemployer pension issues, drafts and designs executive compensation, equity and employment agreements and arrangements, and advises clients on welfare plan design and compliance. Ms. O’Brien has significant ERISA Title I experience and has counseled plan fiduciaries with respect to investment policies, alternative investments, prohibited transaction and payment of expenses from plan assets. She is recognized by Best Lawyers in America and Leading Lawyers in the area of employee benefits (ERISA) law.

“Maureen is a strong addition to our Corporate, M&A and Securities team in Chicago and firmwide. Her practice is sophisticated and her knowledge broad-based,” said José Sirven, leader of Holland & Knight’s Business Section. “Her M&A transaction experience is impressive and complements our existing capabilities in this area.”

Ms. O’Brien received a J.D. degree with high honors from Chicago-Kent College of Law and a B.A. degree from the University of California, Los Angeles.

Source URL: Read More
The public content above was dynamically discovered – by graded relevancy to this site’s keyword domain name. Such discovery was by systematic attempts to filter for “Creative Commons“ re-use licensing and/or by Press Release distributions. “Source URL” states the content’s owner and/or publisher. When possible, this site references the content above to generate its value-add, the dynamic sentimental analysis below, which allows us to research global sentiments across a multitude of topics related to this site’s specific keyword domain name. Additionally, when possible, this site references the content above to provide on-demand (multilingual) translations and/or to power its “Read Article to Me” feature, which reads the content aloud to visitors. Where applicable, this site also auto-generates a “References” section, which appends the content above by listing all mentioned links. Views expressed in the content above are solely those of the author(s). We do not endorse, offer to sell, promote, recommend, or, otherwise, make any statement about the content above. We reference the content above for your “reading” entertainment purposes only. Review “DMCA & Terms”, at the bottom of this site, for terms of your access and use as well as for applicable DMCA take-down request.

1 2